I really like Aspen, its an excellent company, now that GSK is getting a share and working together with them for long term and Aspen having all those advantages that the deal will bring will be a excellent company going forward, their management is excellent Stephen Saad is very very competent and a real innovator. Only problem i have is that it is quite pricey at current levels, i hold shares and will not sell them, but would like to acquire more but at a bit cheaper price... lol... to be honest over the years its been my best performing share, others have surpassed it over the years, but the crisis has shown its strengh and while my other positions lost a bit value, Aspen only grew...
... View more